Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has provided an update.
Suzhou Basecare Medical Corporation Limited has announced a strategic cooperation agreement with Rhea Labs Pte. Ltd. to expand its market in assisted reproductive technologies. The agreement aims to leverage both companies’ strengths to establish AI-powered IVF clinics in various regions, enhancing the company’s market position and benefiting shareholders.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited operates in the medical industry, focusing on assisted reproductive technologies. The company provides a range of medical products and solutions, including pre-implantation genetic testing and equipment for reproductive centers. It aims to innovate in women’s healthcare and expand its presence in the global fertility market.
YTD Price Performance: 22.63%
Average Trading Volume: 90,725
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$949.9M
See more data about 2170 stock on TipRanks’ Stock Analysis page.